Difference between revisions of "Team:CGU Taiwan/standard content"
| Line 46: | Line 46: | ||
<div class="container"> | <div class="container"> | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
<div id="accordion-container"> | <div id="accordion-container"> | ||
| − | + | <h1 class="title text-center wow fadeInDown" data-wow-duration="500ms" data-wow-delay="300ms">Welcome to CGU_Taiwan's Wiki page</h1> | |
<h2 class="text-center padding-bottom wow fadeInDown" data-wow-duration="400ms" data-wow-delay="400ms">Oral cancer is a common cancer worldwide. One of the major problems of oral cancer is that early malignancy could only be detected by clinical oral examination from health care professionals, and there are no clinical tests at the molecular level. Recently, there are several Proteins and mRNAs reported as promising potential non-invasive biomarkers in saliva for oral cancer. Our team wants to establish simple, objective and quantifiable non-invasive detection system for those biomarkers. | <h2 class="text-center padding-bottom wow fadeInDown" data-wow-duration="400ms" data-wow-delay="400ms">Oral cancer is a common cancer worldwide. One of the major problems of oral cancer is that early malignancy could only be detected by clinical oral examination from health care professionals, and there are no clinical tests at the molecular level. Recently, there are several Proteins and mRNAs reported as promising potential non-invasive biomarkers in saliva for oral cancer. Our team wants to establish simple, objective and quantifiable non-invasive detection system for those biomarkers. | ||
<br>Our system includes two aims : | <br>Our system includes two aims : | ||
| Line 59: | Line 55: | ||
<br>2) Synthetic toehold switch gene regulators as RNA sensors to detect specific mRNA biomarkers. These efforts will provide the groundwork for new molecular diagnoses in oral cancer.</h2> | <br>2) Synthetic toehold switch gene regulators as RNA sensors to detect specific mRNA biomarkers. These efforts will provide the groundwork for new molecular diagnoses in oral cancer.</h2> | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| Line 99: | Line 66: | ||
| − | + | ||
| − | + | ||
</div> | </div> | ||
</section> | </section> | ||
Revision as of 08:18, 10 November 2015
